oleanolic acid has been researched along with cysteine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Koike, M; Miyashiro, E; Sumiyama, K | 1 |
| Wang, JT | 1 |
| Iwabuchi, S; Osada, T; Takatori, M; Yoshida, H | 1 |
| Acharya, SK; Dasarathy, S; Joshi, YK; Tandon, A; Tandon, BN | 1 |
| Balderson, GA; Lynch, SV; Matsunami, H; Strong, RW | 1 |
| KIMURA, Y; MAEDA, S; OKAMURA, S | 1 |
| Ishiguro, M; Mikasa, S; Otani, M | 1 |
| Kumada, H; Tsubota, A | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
| Mitsuyoshi, H; Nakashima, T; Okanoue, T; Sumida, Y | 1 |
| Bi, MR; Chen, LY; Ma, YJ; Wang, Y; Yang, BS | 1 |
| Ahmad, R; Kharbanda, S; Kufe, D; Meyer, C; Raina, D | 1 |
| Gribble, GW; Honda, T; Liby, KT; Sporn, MB; Yore, MM | 1 |
| Grudniak, AM; Kurek, A; Szarlak, J; Wolska, KI | 1 |
| Basagni, F; Lanni, C; Minarini, A; Rosini, M | 1 |
| Gatbonton-Schwager, T; Joshi, T; Kensler, TW; Srinivasan, H; Suzuki, T; Wakabayashi, N; Yagishita, Y; Yamamoto, M | 1 |
6 review(s) available for oleanolic acid and cysteine
| Article | Year |
|---|---|
[Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
Topics: Biomarkers; Cysteine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Middle Aged; Oleanolic Acid; RNA, Viral | 1994 |
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
[Treatment of nonalcoholic steatohepatitis (NASH)].
Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Liver Transplantation; Obesity; Oleanolic Acid; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2004 |
Lights and shadows of electrophile signaling: focus on the Nrf2-Keap1 pathway.
Topics: Animals; Antioxidants; Cysteine; Dimethyl Fumarate; Drug Design; Humans; Kelch-Like ECH-Associated Protein 1; Molecular Structure; NF-E2-Related Factor 2; Oleanolic Acid; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Structure-Activity Relationship | 2019 |
2 trial(s) available for oleanolic acid and cysteine
| Article | Year |
|---|---|
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis; Humans; Male; Oleanolic Acid; Plants, Medicinal | 1984 |
A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure.
Topics: Adolescent; Adult; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhiza; Humans; Interferon Inducers; Liver Failure; Male; Middle Aged; Oleanolic Acid; Plants, Medicinal | 1993 |
9 other study(ies) available for oleanolic acid and cysteine
| Article | Year |
|---|---|
Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Infant; Injections, Intravenous; Male; Oleanolic Acid; Solutions; Time Factors; Transfer Factor | 1991 |
Use of glycyrrhizin for recurrence of hepatitis B after liver transplantation.
Topics: Chronic Disease; Cysteine; Drug Combinations; Female; Glycine; Glycyrrhiza; Hepatitis B; Humans; Liver Transplantation; Middle Aged; Oleanolic Acid; Plants, Medicinal; Recurrence | 1993 |
[The effect of strong neominophagen C on the formation of experimental pulmonary tuberculous cavity].
Topics: Cysteine; Drug Combinations; Glycine; Oleanolic Acid; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[A case of acute poisoning caused by the inhalation of a nonselective herbicide REBIN GT SC (butafenacil and glyphosate isopropylamine)].
Topics: Acute Disease; Aged; Cysteine; Drug Combinations; Fluid Therapy; Glutathione; Glycine; Glyphosate; Herbicides; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Infusions, Intravenous; Inhalation Exposure; Male; Oleanolic Acid; Pyrimidines; Treatment Outcome | 2004 |
[Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cysteine; Drug Combinations; Glycine; Glycyrrhiza; Humans; Liver Neoplasms; Oleanolic Acid | 2005 |
Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.
Topics: Cell Line; Cysteine; Enzyme Inhibitors; Humans; I-kappa B Kinase; Mutation; NF-kappa B; Oleanolic Acid; Oxidation-Reduction; Oxygen; Phosphorylation; Recombinant Proteins; Subcellular Fractions; Tumor Necrosis Factor-alpha; U937 Cells | 2006 |
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta.
Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cysteine; Humans; I-kappa B Kinase; Imidazoles; NF-kappa B; Oleanolic Acid; Sulfhydryl Compounds | 2006 |
Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in Escherichia coli.
Topics: Cysteine; Escherichia coli; Gene Expression Regulation, Bacterial; Oleanolic Acid; Regulon; Stress, Physiological; Triterpenes; Ursolic Acid | 2011 |
A Point Mutation at C151 of
Topics: Animals; Cysteine; Cytoprotection; Hepatitis; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oleanolic Acid; Point Mutation; Signal Transduction | 2023 |